Who Owns InMed Pharmaceuticals Inc. (INM)?Hedge Fund & Institutional Holders

$0.84-0.03 (-3.06%)HealthcareNASDAQ

Institutional Holders

5

as of QNaN NaN

Total Institutional Value

$13.3B

% of Float Held

QoQ Change in Holders

+5 / -0

Price History

$0.76$2.59$4.42$6.25$8.08Aug 24Jun 25Mar 26

INM — Biggest Institutional Buyers This Quarter

FundShares AddedValue% of Portfolio
UBS Group AGNew6K$12.6B0.00%
SBI Securities Co., Ltd.New300$621.0M0.00%
AllSquare Wealth Management LLCNew1$2.0M0.00%
Banque Cantonale VaudoiseNew6$00.00%
Federation des caisses Desjardins du QuebecNew1$00.00%

Top Institutional Holders(QNaN NaN)

#FundSharesValue% of PortfolioQoQ Share Change
1UBS Group AG6,106$12.6B0.00%New
2SBI Securities Co., Ltd.300$621.0M0.00%New
3AllSquare Wealth Management LLC1$2.0M0.00%New
4Banque Cantonale Vaudoise6$00.00%New
5Federation des caisses Desjardins du Quebec1$00.00%New

Similar Stocks by Institutional Ownership

As of QNaN NaN, 5 institutional investors hold INM (InMed Pharmaceuticals Inc.). The largest holder is UBS Group AG with $12.6B in shares. This quarter, 5 institutions opened new positions and 0 closed their positions.

Frequently Asked Questions

How many hedge funds own INM?

As of QNaN NaN, 5 institutional investors report holding INM (InMed Pharmaceuticals Inc.) in their 13F filings.

Who is the largest institutional holder of INM?

The largest institutional holder of INM is UBS Group AG with $12.6B in shares.

Is institutional ownership of INM increasing or decreasing?

This quarter, 5 institutions opened new positions in INM and 0 closed their positions.